Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Stefin B and cystatin C deficiency suppresses tumor growth and alters tumor microenvironment in a breast cancer model
Authors:ID Matjan-Štefin, Petra, Institut "Jožef Stefan" (Author)
ID Završnik, Janja, Institut "Jožef Stefan" (Author)
ID Butinar, Miha, Institut "Jožef Stefan" (Author)
ID Mikhaylov, Georgy, Institut "Jožef Stefan" (Author)
ID Turk, Boris, Institut "Jožef Stefan" (Author)
ID Vasiljeva, Olga, Institut "Jožef Stefan" (Author)
Files:URL URL - Source URL, visit https://www.mdpi.com/2073-4409/15/4/360#
 
.pdf PDF - Presentation file, download (1,62 MB)
MD5: 4D905AD1EE4FE6445CD66AB952C76563
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Background/Objectives: Cysteine cathepsins and their endogenous inhibitors have been shown to possess context-dependent functions in cancer progression, including the regulation of tumor metabolic pathways. Stefin B and cystatin C, intracellular and extracellular protease inhibitors, respectively, can modulate tumor biology through protease-dependent and protease-independent mechanisms. This study investigated their combined functions and potential roles as tumor promoters in breast cancer in a spontaneous breast cancer mouse model (PyMT mice). Methods: We generated PyMT transgenic mice lacking both stefin B and cystatin C (double-knockout, DKO) and compared their tumor growth kinetics, proliferation, apoptosis, and metastatic burden with those of wild-type control mice. Immunohistochemistry was performed to characterize tumor macrophage infiltration and polarization. Results: DKO mice demonstrated delayed tumor onset, significantly slower tumor growth, reduced proliferation, increased apoptosis, and fewer lung metastases compared to wild-type controls. Immunohistochemistry revealed enhanced macrophage infiltration of the tumors, accompanied by a pronounced shift toward antitumorigenic M1 (CD86+) polarization, while M2 (CD206+) populations remained unchanged, indicating an immunological reprogramming of the tumor microenvironment toward a pro-inflammatory, tumor-suppressive state. Conclusions: Our results demonstrated a potential function of stefin B and cystatin C as tumor promoters in breast cancer through complementary mechanisms. Simultaneous depletion of both inhibitors revealed synergistic effects and remodeled the immune microenvironment to favor tumor suppression. These results suggest previously unknown roles for stefin B and cystatin C in tumor development and progression, which encourage further investigation of the cancer metabolic mechanisms underlying tumor behavior and their dynamic interplay with the microenvironment.
Keywords:cystatin C, stefin B, tumor microenvironment, cysteine cathepsins, cancer metabolism, protease inhibitors
Publication status:Published
Publication version:Version of Record
Submitted for review:10.01.2026
Article acceptance date:12.02.2026
Publication date:17.02.2026
Publisher:MDPI
Year of publishing:2026
Number of pages:str. 1-19
Numbering:Vol. 15, iss. 4, [article no.] 360
Source:Švica
PID:20.500.12556/DiRROS-29359 New window
UDC:577
ISSN on article:2073-4409
DOI:10.3390/cells15040360 New window
COBISS.SI-ID:277698563 New window
Copyright:© 2026 by the authors.
Note:Nasl. z nasl. zaslona; Soavtorji: Janja Završnik, Miha Butinar, Georgy Mikhaylov, Boris Turk, Olga Vasiljeva; Opis vira z dne 11. 5. 2026;
Publication date in DiRROS:12.05.2026
Views:38
Downloads:22
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Cells
Shortened title:Cells
Publisher:MDPI
ISSN:2073-4409
COBISS.SI-ID:519958809 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0140-2022
Name:Proteoliza in njena regulacija pri zdravju in boleznih

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:17.02.2026
Applies to:VoR

Secondary language

Language:Slovenian
Keywords:cistatin C, stefin B, mikrookolje tumorja, cisteinski katepsini, metabolizem raka


Back